Supplementary Figure 3: Expression of TIM-3 mutants in SPTCL patients and stably transfected HEK-293 cells. | Nature Genetics

Supplementary Figure 3: Expression of TIM-3 mutants in SPTCL patients and stably transfected HEK-293 cells.

From: Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome

Supplementary Figure 3

(a), Flow cytometry of TIM-3 expression on monocytes (CD14+) from a Y82C TIM-3 heterozygous individual shows an intermediate level of expression as compared to TIM-3 expression on patient and control cells. One representative experiment of the four heterozygous individuals analyzed is provided. (b), Complete image of the western blot shown in Fig. 3c.

Back to article page